Taurus individuals can expect a year of economic, professional, and social growth. Saturn and Jupiter's influence will boost income, particularly after March 29th when Saturn transits favorably.

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...